Asthma Microchapters |
Diagnosis |
---|
Other Diagnostic Studies |
Treatment |
Case Studies |
Asthma emergency management On the Web |
American Roentgen Ray Society Images of Asthma emergency management |
Risk calculators and risk factors for Asthma emergency management |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Philip Marcus, M.D., M.P.H. [2]; Associate Editor(s)-in-Chief:
Inhaled β2 agonist, such as albuterol, is the drug of choice for acute severe exacerbation of asthma. In cases of mild to moderate exacerbations, metered-dose inhalation (MDI) of a β2 agonist in conjunction with a spacer may be used. In more severe exacerbations, nebulized β2 agonist has been demonstrated to be most effective. In case of severe exacerbation with non- reponsiveness to β2 agonist inhalation/anticholinergic therapy, parenteral β2 agonist such as terbutaline may be administered. Ipratropium may also be utilized in cases of severe exacerbation.[1] Steroid therapy remains the mainstay of therapy in the treatment of acute and sub-acute phases of exacerbation. Steroids speed in the resolution of airway obstruction and prevent a late-phase response; hence, shown to provide highly beneficial outcomes to patients with acute exacerbation presenting to the emergency department.[2][3]
When an asthma attack is unresponsive to a patient's usual medication, other treatments are available to the physician or hospital. These include:[4]